Login to Your Account

Adolor Inks $265M Deal With Pfizer For Opioid

By Trista Morrison

Thursday, December 6, 2007
Adolor Corp.'s beleaguered shares got a 20 percent boost on Wednesday after the company announced a $265 million deal with Pfizer Inc. for the delta opioid agonists ADL5859 and ADL5747. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription